Axillary surgery: Is it necessary?

Breast

Volumn 9, Issue 1, 2000, Pages 2-4

  Hadjiloucas, Ioannis ^a   Bundred, Nigel J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGING; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SHORT SURVEY; TUMOR VOLUME;

EID: 0034097521     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0124     Document Type: Article

References (42)

1. Lin P P, Allison D C. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol. 11:1993;1536-1544.
2. Kjaergaard J, Blichert-Toft M. Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg. 72:1985;365-367.
3. Fentiman I S, Mansel R E. The axilla: not a no-go zone. Lancet. 337:1991;221-223.
4. Benson E A, Thorogood J. The effect of surgical echnique on local recurrence rates following mastectomy. Eur J Surg Oncol. 12:1986;267-271.
5. Matthiem W, Bougeois P. Axillary dissection in breast cancer revisited. Eur J Surg Oncol. 15:1989;490-495.
6. Bundred N J, Downey S E. The management of early breast cancer. Current Practice in Surgery. 8:1996;1-6.
7. Nemoto T, Vana J. Management and survival of female breast cancer results of a national survey by the American College of Surgeons. Cancer. 45:1980;2917-2924.
8. Kinne D W. Axillary clearance in operable breast cancer: Still a necessity? Recent Results in Cancer Research. 152:1998;161-169.
9. Fentiman I S, Hyland D. Prognosis of patients with breast cancers up to 1 cm in diameter. Eur J Cancer. 32A:1996;417-420.
10. Kissin M W, Thompson E M. The inadequacy of axillary sampling in breast cancer. Lancet. i:1982;1210-1211.
11. Leslie M D, Maher E J. Node negative breast cancer. BMJ. 300:1990;749.
12. Yeoh E K, Denham J W. Primary breast cancer. Complications of axillary management. Acta Radiol Oncol. 25:1986;105-108.
13. Forrest A P M, Everington D. The Edinburgh randomised trial of axillary sampling or clearance after mastectomy. Br J surg. 82:1995;1504-1508.
14. Atkins H J B, Hayward H L. Treatment of early breast cancer: a report after ten years of a clinical trial. BMJ. 2:1972;423-429.
15. Overgaard M, Jensen M. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 353:1999;1641-1648.
16. Fisher B. Breast cancer management: alternatives to radical mastectomy. N Eng J Med. 301:1979;326-328.
17. Tabar L, Fagerberg G. Breast cancer treatment and natural history: new insights from results of screening. Lancet. 339:1992;412-414.
18. Tabar L, Duffy S W. The natural history of breast carcinoma. Cancer. 86:1999;449-462.
19. Holland P A, Walls J. A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds. Br J Cancer. 74:1996;1643-1646.
20. Norden T, Thurfjell E. Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer. 33:1997;624-628.
21. Crisp W J, Higgs M J. Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg. 80:1993;863-865.
22. Veronesi U, Luini A. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 16:1990;127-123.
23. Wallace I W J, Champion H R. Axillary nodes in breast cancer. Lancet. 1:1972;217-218.
24. Sacre R A. Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol. 12:1986;169-173.
25. Bruneton J N, Caramella E. Axillary lymph node metastases in breast cancer: Preoperative detection with US. Radiology. 158:1986;325-326.
26. McLean R G, Ege G N. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med. 27:1986;1116-1124.
27. Isaacs R J, Ford J M. Role of computed tomography in the staging of primary breast cancer. Br J Surg. 80:1993;1137.
28. Ahlgren J, Stal O. Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncol. 33:1994;603-608.
29. Ravdin P M, De Laurentiis M. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst. 86:1994;1771-1775.
30. Axelsson C K, Mouridsen H T. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer. 28A:1992;1415-1418.
31. Flett M M, Going J J. Sentinel node localisation in patients with breast cancer. Br J Surg. 85:1998;991-993.
32. Veronesi U, Paganelli G. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349:1997;1864-1867.
33. Giuliano A E, Kirgan D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-401.
34. Krag D N, Weaver D. Surgical resection and radiolocalisation of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 2:1993;335-339.
35. Stefanik D, Goldberg R. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 3:1985;660-665.
36. McArdle C S, Crawford D. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg. 73:1986;264-266.
37. Griem K L, Henderson I C. The 5-year results of a randomised trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol. 5:1987;1546-1555.
38. Fowble B, Fein D A. The impact of tamoxifen on breast recurrence, cosmesis, complications and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiation Oncology Biol Phys. 35:1996;669-677.
39. Fisher B J, Perera F E. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence. Int J Radiation Oncology Biol Phys. 42:1998;117-123.
40. Velez-Garcia E, Carpenter J T Jr. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a south-eastern cancer study group (SEG) trial. Eur J Cancer. 28A:1992;1833-1837.
41. Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom, 1998.
42. Fisher B, Slack N H. Cancer of the breast: Size of neoplasm and prognosis. Cancer. 24:1969;1071-1080.